 |
|
New tool to speed cancer therapy approval available
September 15, 2008PHILADELPHIA - Although cancer remains a leading cause of death in America, it can take up to 12 years to bring a new anti-cancer agent before the FDA and the success rate for approval is only five to 10 percent. That means many research hours and dollars are wasted chasing avenues that will not bring fruit.
The National Cancer Institute's Translational Research Working Group (TRWG) developed a set of tools that it believes will improve that process. The tools, known as "Pathways to Clinical Goals" are published in the September 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
"The NCI supports a great deal of excellent translational research, but inefficiencies arising from a lack of communication and coordinated effort prevent many promising leads from reaching clinical trials and eventual approval," said Lynn Matrisian, Ph.D, a special assistant in the Office of the Director, NCI. Matrisian co-chaired the TRWG, which was formed in 2005 with the goal of accelerating the pace of translational cancer research. Publication of the Pathways is expected to be a major step forward in this process.
There are six Pathways that address the following categories: anti-cancer agents (drugs or biologics), biospecimen-based assessment methods, immune response modifiers, image-based assessment modalities, intervention devices, and lifestyle alterations.
Each pathway is a flowchart with a series of steps intended to clarify and streamline the translational research process. For example, in the anti-cancer agent pathway, researchers are encouraged at the outset to address the following three questions:
* Is the empirical basis for attributing clinical potential (alone and/or in combination) convincing?
* Does the envisioned clinical need justify expenditure of resources?
* Is it feasible to identify/develop an agent against this target?
If the answer to any of these questions is "no," then research leaders are encouraged to direct their research toward more effective plans.
Matrisian and her colleagues hope that the TRWG pathways will be widely used and that they will make the early translational research process more efficient.
"The NCI funds many important research projects, and we hope these pathways will help in placing each research opportunity in the broader context of tangible cancer detection, diagnosis, prevention, and treatment strategies. We believe the NCI 's experience will be an important resource for other groups advancing translational research as well," said Matrisian.
American Association for Cancer Research
There are six Pathways that address the following categories: anti-cancer agents (drugs or biologics), biospecimen-based assessment methods, immune response modifiers, image-based assessment modalities, intervention devices, and lifestyle alterations.
Each pathway is a flowchart with a series of steps intended to clarify and streamline the translational research process. For example, in the anti-cancer agent pathway, researchers are encouraged at the outset to address the following three questions:
* Is the empirical basis for attributing clinical potential (alone and/or in combination) convincing?
* Does the envisioned clinical need justify expenditure of resources?
* Is it feasible to identify/develop an agent against this target?
If the answer to any of these questions is "no," then research leaders are encouraged to direct their research toward more effective plans.
Matrisian and her colleagues hope that the TRWG pathways will be widely used and that they will make the early translational research process more efficient.
"The NCI funds many important research projects, and we hope these pathways will help in placing each research opportunity in the broader context of tangible cancer detection, diagnosis, prevention, and treatment strategies. We believe the NCI 's experience will be an important resource for other groups advancing translational research as well," said Matrisian.
American Association for Cancer Research
Translational Research Current Events and Translational Research News RSSStem Cells from Monkey Teeth Can Stimulate Growth and Generation of Brain Cells
Researchers at the Yerkes National Primate Research Center, Emory University, have discovered dental pulp stem cells can stimulate growth and generation of several types of neural cells. Findings from this study, available in the October issue of the journal Stem Cells, suggest dental pulp stem cells show promise for use in cell therapy and regenerative medicine, particularly therapies associated with the central nervous system.
Can vitamins and minerals prevent hearing loss?
About 10 million people in the United States alone-from troops returning from war to students with music blasting through headphones-are suffering from impairing noise-induced hearing loss.
Engineered killer T cell recognizes HIV-1's lethal molecular disguises
Researchers at the University of Pennsylvania School of Medicine and colleagues in the United Kingdom have engineered T cells able to recognize HIV-1 strains that have evaded the immune system.
Ultrasound shown to exert remote control of brain circuits
In a twist on nontraditional uses of ultrasound, a group of neuroscientists at Arizona State University has developed pulsed ultrasound techniques that can remotely stimulate brain circuit activity.
Scientists close in on method to fight deadly childhood cancer
A multicenter team of researchers, including scientists from the University of Florida, has discovered a way to potentially block the growth of neuroblastoma, a type of cancer responsible for 15 percent of all cancer deaths in children.
Drinking alcohol before 15 years of age is risky for later alcohol problems
It may seem like a minor point, but it matters when someone takes their first drink of alcohol relative to later development of alcohol problems. A new study of the relationship between age at first drink (AFD) and the risk of developing alcohol-use disorders (AUDs) during adulthood has found that the risk is greatest when AFD occurs before the age of 15.
Newly found gene variants account for kidney diseases among African-Americans
For the first time, researchers have identified variations in a single gene that are strongly associated with kidney diseases disproportionately affecting African-Americans. This work was conducted by researchers at the National Institutes of Health (NIH) and by NIH-funded investigators at the Johns Hopkins University.
Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism
In a case-control study, the presence of measles virus RNA was no more likely in children with autism and GI disturbances than in children with only GI disturbances.
VCU Massey Cancer Center Spearheads Novel Clinical Study for Lymphoma Patients
The Virginia Commonwealth University Massey Cancer Center recently opened a National Cancer Institute (NCI)-sponsored, phase II clinical study for certain sub-types of non-Hodgkin's lymphoma.
New disease-fighting nanoparticles look like miniature pastries
Ultra-miniature bialy-shaped particles - called nanobialys because they resemble tiny versions of the flat, onion-topped rolls popular in New York City - could soon be carrying medicinal compounds through patients' bloodstreams to tumors or atherosclerotic plaques.
More Translational Research Current Events and Translational Research News Articles
 | Biomedical Informatics in Translational Research by Hai Hu, Richard J. Mural, Michael N. Liebman This groundbreaking resource on biomedical informatics gives you step-by-step insight into innovative techniques for integrating and federating data from clinical and high-throughput molecular study platforms as well as from the public domain. It details how to apply computational and statistical technologies to clinical, genomic, and proteomic studies to enhance data collection, tracking,... |
 | Translational Research in Genetics and Genomics by Moyra Smith |
 | ESMO Handbook on Principles of Translational Research (European Society for Medical Oncology Handbooks) This source presents the principles of cell biology, cellular pathways, and their implications for drug development in oncology. Using state-of-the-art and evidence-based literature references and reviews, with illustrations as necessary, the authors present an overview that is both reliable and easily... |
 | Translational and Experimental Clinical Research This volume is a comprehensive textbook for investigators entering the rapidly growing field of translational and experimental clinical research. The book offers detailed guidelines for designing and conducting a study and analyzing and reporting results and discusses key ethical and regulatory issues. Chapters address specific types of studies such as clinical experiments in small numbers of... |
 | Translational Pain Research: Comparing Preclinical Studies And Clinical Pain Management. Lost in Translation? |
 | Human Cancer Viruses: Principles of Transformation and Pathogenesis (Translational Research in Biomedicine) The first identification of a tumor-causing virus, Rous sarcoma virus, occurred almost 100 years ago, but it was not until the 1970s that the genetic basis for oncogenesis by this and other acutely transforming retroviruses was appreciated. Since then, numerous viral oncogenes and their corresponding cellular proto-oncogene counterparts have been identified, and these studies have contributed... |
 | Minnesota Symposia on Child Psychology: Meeting the Challenge of Translational Research in Child Psychology (The Minnesota Symposia on Child Psychology) by Dante Cicchetti, Megan R. Gunnar The collected papers from this symposia provide scholars, students, and practitioners with access to the newest work of top tier scientists in psychology. Volume 35 addresses issues relevant to disorders of development and presents their processes and findings. It covers the translation of research on learning, attention/attention deficit, and early conduct problems into practice at a clinical... |
| Role of corticotropin releasing factor in anxiety disorders: A translational research perspective [An article from: Hormones and Behavior] by V.B. Risbrough, M.B. Stein This digital document is a journal article from Hormones and Behavior, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.Description: Anxiety disorders are a group of mental disorders that include generalized anxiety disorder (GAD), panic disorder, phobic... | |
 | Melanoma: Translational Research and Emerging Therapies (Translational Medicine) Assembling, reviewing, and synthesizing state-of-the-art information on translational research and therapies of melanoma into one convenient source, Melanoma: Translational Research and Emerging Therapies provides clinicians and researchers the necessary context and perspective to integrate and effectively deploy cutting-edge therapies into daily... |
| Fear and Anxiety: The Benefits of Translational Research Animals, like people, experience fear and avoidance, which can be reliably observed, quantified, and manipulated in almost all species. Remarkably, as this volume demonstrates, the neural circuits responsible for the acquisition and expression of fear are conserved throughout phylogeny from rodents through nonhuman primates to humans. Thus, what is discovered about the neuroanatomy and... |
| © 2008 BrightSurf.com |